ACTT Med Inc

Alternating Current Treatment Therapy Medical, or ACTT Med Inc, is a company focused on developing a device that utilizes alternating current treatment therapy. This therapy aims to support immune function and potentially disrupt the multiplication of diseased cells. The company is located in Kennewick, Washington, with an address at 320 N Johnson St Ste 300, Kennewick, WA 99336. ACTT Med operates within the healthcare, biotechnology, medical devices, and research and development industries. ACTT Med has conducted laboratory tests on various pathogens and cancers, demonstrating promising results. The company's leadership team is composed of experienced professionals. Mike Colton serves as the Chief Executive Officer, and Rodolfo Nicacio O.D. is the Chief Operation Officer. Solomon Erpasa holds the position of Senior Development Engineer, and Chris Pavel is the Chief Strategy Officer, based in the Seattle office. The Board of Directors includes Bill Pagels. The Medical Advisory Committee is led by Dr. Jaime A. Nicacio MD. Lisa Tkachuk serves as an Advisor for Clinical Development, Anna Metcalfe as an Advisor for Regulatory Affairs, and Kim McDonald-Taylor as an Advisor for Clinical Research & Quality Assurance. ACTT Med's competitive advantages include over 40 years of experience in bringing new products to market. The team also has 35 years of business management experience, 10 years of experience in electrical circuit board design and manufacturing, and over 21 years of expertise within the Department of Defense. Furthermore, the company benefits from 14+ years of global marketing experience and 40+ years of experience in product development and commercialization. The company's values and culture are centered around innovation, research and development, global healthcare impact, and a client-first approach. ACTT Med can be contacted via phone at 509-518-2401 or by email at [email protected].